Evaluation of Serum Leptin Level in Males with Elevated Blood Pressure

Authors

  • Maryam Hani Abduljalal university of Mosul College of medicine http://orcid.org/0000-0003-4589-8558
  • Nuha Abdulkadir Shareef University of Mosul, College of Science
  • Sarmad Osama Alfeel Directorate of Ninevah Health

DOI:

https://doi.org/10.46328/ijonest.50

Keywords:

Leptin, Obesity, Body Mass Index, Hypertension, Lipid profile

Abstract

Leptin is a hormone secreted from adipose tissue, proved to be related to inflammatory, hemostatic, and metabolic factors, and thought to be involved in the development of hypertension. We aim to evaluate serum leptin levels and lipid profile in males with elevated blood pressure to be compared with healthy controls males of matched body mass index (BMI) and age. The present study were included 50 subject, 24 healthy controls males whose BMI (Mean±SD 27.6±4.9) as control group and 26 hypertensive males with essential hypertension whose BMI (Mean±SD 28.3±3.4), those two groups were aged and BMI matched Fasting serum leptin level, triglyceride (TG), total serum cholesterol, high density lipoprotein(HDL) and low density lipoprotein(LDL) were measured. Leptin was found to be significantly higher in the hypertensive males (group2) when compared with the control group (group1) (21.5±2.3ng/ml against 14.3±1.4 ng/ml, respectively; p<0.03), while a very high significant difference in triglyceride, systolic and diastolic blood pressure (p <0.0001) and a significant difference in cholesterol was (p 0.01), LDL was (p<0.01) and HDLwas (p<0.05). The present study concluded that male patients with elevated blood pressure had significantly higher serum leptin level compared with healthy subjects of a same BMI. More over patients with hypertension had an unfavorable lipid profile.

Author Biography

Maryam Hani Abduljalal, university of Mosul College of medicine

 department of biochemistry

References

Abduljalal, M. H., Shareef, N. A., & Alfeel, S. O. (2021). Evaluation of Serum Leptin Level in Males with Elevated Blood Pressure. International Journal on Engineering, Science and Technology (IJonEST), 3(2), 87-90.

Downloads

Published

2022-01-16

Issue

Vol. 3 No. 2 (2021)

Section

Science

License

Articles may be used for research, teaching, and private study purposes. Authors alone are responsible for the contents of their articles. The journal owns the copyright of the articles. The publisher shall not be liable for any loss, actions, claims, proceedings, demand, or costs or damages whatsoever or howsoever caused arising directly or indirectly in connection with or arising out of the use of the research material.

The author(s) of a manuscript agree that if the manuscript is accepted for publication in the International Journal on Engineering, Science and Technology (IJonEST), the published article will be copyrighted using a Creative Commons “Attribution 4.0 International” license. This license allows others to freely copy, distribute, and display the copyrighted work, and derivative works based upon it, under certain specified conditions.

Authors are responsible for obtaining written permission to include any images or artwork for which they do not hold copyright in their articles, or to adapt any such images or artwork for inclusion in their articles. The copyright holder must be made explicitly aware that the image(s) or artwork will be made freely available online as part of the article under a Creative Commons “Attribution 4.0 International” license.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.